The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Arushanian É.B.

Kafedra farmakologii Stavropol'skoĭ gosudarstvennoĭ meditsinskoĭ akademii

Melatonin and diabetes mellitus (an overview of current experimental data)

Authors:

Arushanian É.B.

More about the authors

Journal: Problems of Endocrinology. 2012;58(3): 35‑40

Views: 10554

Downloaded: 152

Download PDF (RU)
Contact the author
Table of contents

MELATONIN AND DIABETES MELLITUS (AN OVERVIEW OF CURRENT EXPERIMENTAL DATA)
MELATONIN AND DIABETES MELLITUS (AN OVERVIEW OF CURRENT EXPERIMENTAL DATA)

To cite this article:

Arushanian ÉB. Melatonin and diabetes mellitus (an overview of current experimental data). Problems of Endocrinology. 2012;58(3):35‑40. (In Russ.)

МСФ на ЯМ
Close metadata
Recommended articles:
Outcomes of bima­nual vitreoretinal surgery in the treatment of diabetic reti­nopathy complications. Russian Annals of Ophthalmology. 2024;(2-2):21-27
Impact of SGLT2 inhi­bitors on erythropoiesis and iron exchange in patients with diabetes mellitus and chro­nic heart failure. Russian Journal of Preventive Medi­cine. 2024;(5):103-110
Inci­dence of carbohydrate meta­bolism diso­rder in iron overload of different etiology. Russian Journal of Preventive Medi­cine. 2024;(5):111-117
Ultrastructural characteristics of transplantable B16 mela­noma cells under the influence of constant darkness. Rege­nerative Biotechnologies, Preventive, Digi­tal and Predictive Medi­cine. 2024;(1):21-29
Mela­tonin at the health-resort stage of treatment and reha­bilitation in national practice. Rege­nerative Biotechnologies, Preventive, Digi­tal and Predictive Medi­cine. 2024;(1):55-59
Fatal case of rhinocerebral muco­rmycosis on the background of type II diabetes mellitus. Russian Journal of Archive of Pathology. 2024;(3):52-58
Enda­rterectomy from supe­rficial femo­ral artery in patients with type 2 diabetes mellitus. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(3):285-293
Evaluation of reva­scularization effi­ciency using near-infrared oximetry in patients with diabetic foot syndrome. Piro­gov Russian Journal of Surgery. 2024;(6):20-27
Features of the oral microbiota in patients with type II diabetes in the background of dental implantation. Russian Journal of Stomatology. 2024;(2):21-26
The problem of diabetes mellitus in obstetrics. Russian Bulletin of Obstetrician-Gynecologist. 2024;(3):25-29

Melatonin secreted by the epiphysis and synthesized in adipocytes of the gastrointestinal tract participates in the regulation of carbohydrate metabolism by modulating activities of alpha- and beta cell of Langerhans islets in the pancreas; melatonin acts via its specific receptors (MT1 and MT2). Reciprocal interactions between melatonin and insulin have been demonstrated while melatonin deficiency is known to be one of the factors predisposing to the development of diabetes mellitus. It was shown that melatonin provides protection against diabetes through a variety of intracellular and systemic mechanisms.

Keywords:

melatonin
carbohydrate metabolism
diabetes mellitus
antagonism with insulin

Authors:

Arushanian É.B.

Kafedra farmakologii Stavropol'skoĭ gosudarstvennoĭ meditsinskoĭ akademii

List of references:

  1. Anisimov V.N. Melatonin: rol' v organizme, primenenie v klinike. Sistema. SPb 2007.
  2. Arushanyan E.B. Unikal'nyi melatonin. Stavropol' 2007.
  3. Reiter R.J. Pineal melatonin: cell biology of its synthesis and its physiological interactions. Endocrinol Rev 1991; 12: 151-180.
  4. Raikhlin N.T., Kvetnoi I.M., Osadchuk M.A. APUD-sistema (obshchebiologicheskie i onkologicheskie aspekty). Obninsk 1993.
  5. Bubenik G.A. Thirty four years since the discovery of gastrointestinal melatonin. J Physiol Pharmacol 2008; 59: 33-51.
  6. Konturek S.J., Konturek P.C., Brzozowska I., Pawlik M., Sliwowski Z., Cześnikiewicz-Guzik M., Kwiecień S., Brzozowski T., Bubenik G.A., Pawlik W.W. Localization and biological activities of melatonin in intact and diseased gastrointestinal tract. J Physiol Pharmacol 2007; 58: 381-405.
  7. Ishii H., Tanaka N., Kobayashi M., Kato M., Sakuma Y. Gene structures, biochemical characterization and distribution of rat melatonin receptors. J Physiol Sci 2009; 59: 37-47.
  8. Stebelova K., Anttila K., Manttori S., Saarela S., Zeman M. Immunohistochemical definition of MT(2) receptors and melatonin in the gastrointestinal tissues of rat. Acta Histochem 2010; 112: 26-33.
  9. Kvetnoi I.M., Kvetnaya T.V., Raikhlin N.T. Ekstrapineal'nyi melatonin: mesto i rol' v neiroendokrinnoi regulyatsii gomeostaza. Melatonin v norme i patologii. Medpraktika. M 2004; 34-47.
  10. Hardeland R., Cardinali D.P., Srinivasan V., Spence D.W., Brown G.M., Pandi-Perumal S.R. Melatonin - a pleotropic, orchestrating regular molecule. Progr Neurobiol 2011; 93: 350-384.
  11. Bojkova B., Orendas P., Friedmanova L., Kassayová M., Datelinka I., Ahlersová E., Ahlers I. Prolonged melatonin administration in 6-month-old Sprague-Dawley rats: metabolic alterations. Acta Physiol Hung 2008; 95: 65-76.
  12. Sudnikovich E.J., Maksimchnik K.J., Zabrodskaya S.V., Kubyshin V.L., Lapshina E.A., Bryszewska M., Reiter R.J., Zavodnik I.B. Melatonin attenuates metabolic disorders due to streptozotocin-induced diabetes in rat. Eur J Phrmacol 2007; 569: 180-187.
  13. Bahr I., Muhlbauer E., Schulte H., Peschke E. Melatonin stimulates glucagon secretion in vitro and in vivo. J Pineal Res 2011; 50: 336-344.
  14. Cagnacci A., Arangino S., Renzi A., Paoletti A.M., Melis G.B., Cagnacci P., Volpe A. Influence of melatonin administration on glucose tolerance and insulin sensitivity of postmenopausal women. Clin Endocrinol 2001; 54: 339-346.
  15. Darul K., Kruczynska H. Effect of melatonin on biochemical variables of the blood in dairy cows. Acta Vet Hung 2004; 52: 361-367.
  16. Chandra R., Liddle R.A. Neural and hormonal regulation of pancreatic secretion. Curr Opin Gastroenterol 2009; 25: 441-446.
  17. Peschke E., Mulhbauer E. New evidence for a role of melatonin in glucose regulation. Best Pract Res Clin Endocrinol Metab 2010; 24: 892-941.
  18. Mazepa R.C., Cuevas M.J., Collado P.S. Melatonin increases muscle and liver glycogen in nonexercised and excercised rats. Life Sci 2000; 66: 153-160.
  19. Rios-Lugo M.J., Cano P., Jimenez-Ortega V., Fernández-Mateos M.P., Scacchi P.A., Cardinali D.P., Esquifino A.I. Melatonin effect on plasma adiponectin, leptin, insulin, glucose, triglycerides and cholesterol in normal and high fat-fed rats. J Pineal Res 2010; 49: 342-348.
  20. Akmali M., Ahmadi R., Vessal M. Pre- and post-treatment of streptozotocin administrated rats with melatonin: effects on some hepatic enzymes of carbohydrate metabolism. Arch Iran Med 2010; 13: 105-110.
  21. Nishida S. Metabolic effects of melatonin on oxidative stress and diabetes mellitus. Endocrine 2005; 27: 131-136.
  22. Peschke E. Melatonin, endocrine pancreas and diabetes. J Pineal Res 2008; 44: 26-40.
  23. Kasradze D., Tavartkiladze A., Kasradze M. The study of melatonin protective activity on pancreatic beta-cells under the condition of alloxan-induced diabetes during aging. Georgian Med News 2010; 189: 56-63.
  24. Picinato M.C., Hirata A.E., Cipolla-Neto J., Curi R., Carvalho C.R., Anhê G.F., Carpinelli A.R. Activation of insulin and IGF-1 signaling pathways by melatonin through MT1 receptor in isolated rat pancreatic islets. J Pineal Res 2008; 44: 88-94.
  25. Shieh J.M., Wu H.T., Cheng K.C. Melatonin ameliorates high fat diet-induced diabetes and stimulates glycogen synthesis via a PKCzeta-Akt-Gsk3-beta pathway in hepatic cells. J Pineal Res 2009; 47; 339-344.
  26. Lin G.J., Huang S.H., Hueng D.J., Chen Y.W., Chien M.W., Chia W.T., Chang D.M., Sytwu H.K. Melatonin prolongs islet graft survival in diabetic NOD mice. J Pineal Res 2009; 47: 284-292.
  27. Robeva R., Kiriliv G., Tomova A. Melatonin-insulin interactions in patients with metabolic syndrome. J Pineal Res 2008; 44: 52-56.
  28. Kedziora-Kornatowska, Szewczyk-Golec K., Kozakiewicz M., Pawluk H., Czuczejko J., Kornatowski T., Bartosz G., Kedziora J. Melatonin improves oxidative stress parameters measured in the blood of elderly type 2 diabetic patients. J Pineal Res 2009; 46: 333-337.
  29. Nagorny C.L., Sathanoori R., Voss U., Mulder H., Wierup N. Distribution of melatonin receptors in murine pancreatic islets. J Pineal Res 2011; 50: 412-417.
  30. Del Castillo-Vaguero A., Salido G.M, Gonzalez A. Melatonin induces calcium release from CCK-8 and thapsigargin-sensitive cytosolic stores in pancreatic AR 42I cells. J Pineal Res 2010; 49: 256-263.
  31. Peschke E., Bach A.G., Muhlbauer E. Parallel signaling pathways of melatonin in the pancreatic beta-cells. J Pineal Res 2006; 40: 184-191.
  32. Ramracheya R.D., Muller D.S., Squires P.E., Brereton H., Sugden D., Huang G.C., Amiel S.A., Jones P.M, Persaud S.J. Function and expression of melatonin receptors on human pancreatic islets. J Pineal Res 2008; 44: 273-279.
  33. Stumpf I., Bazwinsky I., Peschke E. Modulation of the cGMP signaling pathway by melatonin in pancreatic beta-cells. J Pineal Res 2009; 46: 140-147.
  34. Stumpf I., Muhlbauer E., Peschke E. Involvement of the cGMP pathway in mediating the insulin-inhibitory effect of melatonin in pancreatic beta-cells. J Pineal Res 2008; 45: 318-327.
  35. Mulder H., Nagorny C.L., Lyssenko V. Melatonin receptors in pancreatic islets: good morning to a novel type 2 diabetes gene. Diabetologia 2009; 52: 1240-1249.
  36. Conteras-Alcantara S., Baba K., Tosini G. Removal of melatonin receptor type 1 induces insulin resistance in the mouse. Obesity 2010; 16: 1861-1863.
  37. Mussig K., Staiger H., Machicao F., Häring H.U., Fritsche A. Genetic variations in MTNR1B affecting insulin secretion. Ann Med 2010; 42: 387-393.
  38. Reinehr T., Scherag A., Wang Y., Roth C.L., Kleber M., Scherag S., Boes T., Vogel C., Hebebrand J., Hinney A. Relationship between MTNR1B (melatonin receptor 1B gene) polymorphism rs 10830963 and glucose levels in overweight children and adolescents. Pediat Diabet 2011; 10: 1399-1444.
  39. Peschke E., Wolgast S., Bazwinsky I., Pönicke K., Muhlbauer E. Increased melatonin synthesis in pineal gland of rats in streptozotocin-induced type 1 diabetes. J Pineal Res 2008; 45: 439-448.
  40. Stebelova K., Herichova I., Zeman M. Diabetes induces changes in melatonin concentrations in peripheral tissues of rat. Neuro Endocrinol Lett 2007; 28: 459-465.
  41. Bach A.G., Muhlbauer E., Peschke E. Adrenoreceptor expression and diurnal rhythms of melatonin and its precursors in the pineal gland of types 2 diabetes Goto-Kakizaki rats. Endocrinology 2010; 151: 83-93.
  42. Frese T., Bach A.G., Muhlbauer E., Pönicke K., Brömme H.J., Welp A., Peschke E. Pineal melatonin synthesis is decreased in type 2 diabetic Goto-Kakizaki rats. Life Sci 2009; 85: 526-533.
  43. Peliciart-Garcia R.A., Marcal A.C., Silva J.A., Carmo-Buonfiglio D., Amaral F.G., Afeche S.C., Cipolla-Neto J., Carvalho C.R.O. Insulin temporal sensitivity and its signaling pathway in the pineal gland. Life Sci 2010; 87: 169-174.
  44. Peschke E., Frese T., Chankiewitz E., Peschke D., Preiss U., Schneyer U., Spessert R., Mühlbauer E. Diabetic Goto Kakizaki rats as well type 2 diabetic patients show a decreased diurnal serum melatonin level and an increased pancreatic melatonin-receptor status. J Pineal Res 2006; 40: 135-143.
  45. Allegra M., Reiter R.J., Tan D.X., Gentile C., Tesoriere L., Livrea M.A. The chemistry of melatonin's interaction with reactive species.J Pineal Res 2003; 34: 1-10.
  46. Arushanyan E.B., Beier E.V. Immunotropnye svoistva epifizarnogo melatonina. Eksper i klin farmakol 2002; 65: 73-80.
  47. Maldonado M.D., Perez-San-Gregorio M.A., Reiter R.J. The role of melatonin in the immuno-neuro-psychology of mental disorders. Recent Pat. CNS Drug Dis 2009; 4: 61-69.
  48. Srinivasan V., Maestroni G.J., Cardinali D.P., Esquifino A.I., Pandi Perumal S.R., Miller S.C. Melatonin, immune function and aging. Immun Aging 2005; 2: 17-27.
  49. Zawilska J.B., Skene D.J., Arendt J. Physiology and pharmacology of melatonin in relation of biological rhythms. Pharmacol Rep 2009; 61: 383-410.
  50. Muhlbauer E., Gross E., Labucay K., Wolgast S., Peschke E. Loss of melatonin signallig and its impact on circadian rhythms in mouse organ regulating blood glucose. Eur J Pharmacol 2009; 606: 61-71.
  51. Srivastava R.K., Krishna A. Melatonin modulates glucose homeostasis during winter dormancy in a vespertillionid bat Scotophilus heathi. Comp Biochem Physiol Mol Int Physiol 2010; 155: 392-400.
  52. Arushanyan E.B., Arushanyan L.G., El'bek'yan K.S. Mesto epifizarno-adrenokortikal'nykh otnoshenii v popravochnoi regulyatsii povedeniya. Uspekhi fiziol nauk 1993; 24: 73-79.
  53. Nduhirabandi F., Du Toit E.F., Blackhurst D., Marais D., Lochner A. Chronic melatonin consumption prevents obesity-related metabolic abnormalities and protects the heart against myocardial ischemic and reperfusion injury in a prediabetic model of diet-induced obesity. J Pineal Res 2011; 50: 171-182.
  54. Sartori C., Dessen P., Mathieu C., Monney A., Bloch J., Nicod P., Scherrer U., Duplain H. Melatonin improve glucose homeostasis and endothelial vascular function in high-fat diet-fed insulin-resistant mice. Endocrinology 2009; 150: 5311-5317.
  55. Agrawal R., Tyangi E., Shukla R. Insulin receptor signaling in rat hippocampus: a study in STZ (ICV)-induced memory deficit model. Eur Neuropsychopharmacol 2011; 21: 261-273.
  56. Guven A., Yavus O., Cam M. Central nervous system complications of diabetes in streptozotocin-induced diabetic rats: a histophatological and immunohistochemical examination. Int J Neurosci 2009; 119: 1156-1169.
  57. Agrawal R., Tyangi E., Shukla R. Effect of insulin and melatonin on acetylcholinesterase activity in the brain of amnesic mice. Behav Brain Res 2008; 189: 381-386.
  58. Sivakumar V., Ling E.A., Lu J. Role of glutamate and its receptors and hypoxia-induced periventricular white matter injury. Glia 2010; 58: 507-523.
  59. Franca E.L., Feticano N.D., Silva K.A., Ferrari C.K., Honorio-França A.C. Modulatory role of melatonin on superoxide release by spleen macrophages isolated from alloxan-induced diabetic rats. Bratisl Lek Listy 2009; 110: 517-522.
  60. Salem A.H., Nosseir N.G., El Bardawi M.G., Shoair M.I., Fadel R.A. Growth assessment of diabetic rat fetuses under the influence of insulin and melatonin: a morphologic study. Antropol Anz 2010; 68: 129-138.

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.